Josephine A. Stanton

Statistics

Publications

Citations

1.3K

H-Index

Active since

1990

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Bioanalytica (Switzerland)

Queen's Medical Centre

University of Nottingham

Josephine A. Stanton is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

MedicinePharmacologyBiochemistryNeuropharmacologyDrug DiscoveryPharmacotherapyMolecular PharmacologyNatural SciencesMedicinal ChemistryNeuroscience

Publications per year

1990–2005

Publications

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

Martin R. Guscott, Linda J. Bristow, Karen L. Hadingham et al. · Neuropharmacology · 2005 · 227 citations

Psychiatry, Functional Selectivity, Medicine +12

Novel 5-HT3 antagonists. Indole oxadiazoles

Christopher J. Swain, Robert J. Baker, Clare O. Kneen et al. · Journal of Medicinal Chemistry · 1991 · 166 citations · Full text

Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT<sub>1D</sub> Receptor Ligands with Improved Pharmacokinetic Profiles

Monique B. van Niel, Ian Collins, Margaret S. Beer et al. · Journal of Medicinal Chemistry · 1999 · 157 citations · Full text

Combinatorial Chemistry, Molecular Pharmacology, Medicinal Chemistry +15

The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor

Martin R. Guscott, E. Egan, G.P. Cook et al. · Neuropharmacology · 2003 · 99 citations

5-Ht7 Receptor, Molecular Physiology, Neurophysiology +5

Characterisation of a cloned human 5-HT1A receptor cell line using [35S]GTPγS binding

Josephine A. Stanton, Margaret S. Beer · European Journal of Pharmacology · 1997 · 77 citations

Signal Transduction, G Protein-coupled Receptor, Immunology +4

1–5 of 22